ACE and Type 2 Diabetes Risk: A Mendelian Randomization Study.

Marie PigeyreJennifer SjaardaMichael ChongSibylle HessJackie BoschSalim YusufUlagamadesan Venkatesan Guillaume Paré

Published in: Diabetes care (2020)

These results support the causal protective effect of ACE inhibitors on type 2 diabetes risk and may guide therapeutic decision making in clinical practice.

Keyphrases

type diabetes
clinical practice
glycemic control
angiotensin ii
angiotensin converting enzyme
metabolic syndrome